Masarykova Univerzita
Masarykova Univerzita is recorded as a service provider in 10 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 10 of 10 trials · Latest update first
ANtibiotic TReatment OPtimisation – randomised controlled trial of Clostridioides difficile infection therapy (ANTROP-I)
Sponsor Fakultni Nemocnice Bulovka
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (15 cycles) venetoclax/ pirtobrutinib vs. MRD-guided venetoclax/ pirtobrutinib in patients with previously untreated chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL) aiming to establish measurement of individual residual disease for adjustment of treatment duration to improve outcomes (CLL18/MOIRAI)
Sponsor University Of Cologne
- Start (EU)
- Latest update
- Estimated end
Psilocybin – a strategy for rapid antidepressant response in depression comorbid with cancer: a randomized double-blind study with the option to enter an open-label extension
Sponsor Narodni Ustav Dusevniho Zdravi
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase 2 study of belantamab mafodotin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
Sponsor Ceska Myelomova Skupina z.s.
- Start (EU)
- Latest update
- Estimated end
- Not reported
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
Sponsor The University Of Birmingham
- Start (EU)
- Latest update
- Estimated end
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma
Sponsor The University Of Birmingham
- Start (EU)
- Latest update
- Estimated end
Psilocybin versus ketamine – fast acting antidepressant strategies in treatment-resistant depression
Sponsor Narodni Ustav Dusevniho Zdravi
- Start (EU)
- Latest update
- Estimated end
- Not reported
The Impact of Inhaled Furosemide and Perorally Administered Levodropropizine on Dyspnea in Patients With Advanced Respiratory Diseases (INFURO)
Sponsor Fakultni Nemocnice Hradec Kralove
- Start (EU)
- Latest update
- Estimated end
- Not reported
A randomized, placebo-controlled, double-blind clinical trial evaluating the safety and efficacy of parecoxib in hospitalized patients with spontaneous subarachnoid hemorrhage
Sponsor Fakultni Nemocnice U Sv Anny V Brne
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Randomised, double-blinded, placebo-controlled, multicenter study of efficacy, safety and side effects of highly diluted atropine collyrium in slowing the progression of myopia (shortsightedness) in children
Sponsor Fakultni Nemocnice Brno
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Masarykova Univerzita?
The 2026-10-09 snapshot links Masarykova Univerzita to 10 distinct CTIS trials. Recorded services include Regulatory services, Clinical monitoring, Data management, Safety reporting & pharmacovigilance, among 11 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Masarykova Univerzita?
The most frequently recorded therapeutic areas are Haematological Malignancies, Gastroenterology, Infectious Disease, Psychiatry. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Masarykova Univerzita conducted?
The linked trials record locations in 18 countries, including Czechia, Austria, Belgium, Germany, Denmark. These are trial locations, not confirmed office locations or countries where Masarykova Univerzita delivered services.
What can this page tell me about Masarykova Univerzita's trial experience?
Browse 10 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Masarykova Univerzita. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Masarykova Univerzita